Herein, we first detected FOXO3A by immunohistochemical analysis of UTUC patients and then investigated any potential association between FOXO3A and clinicopathologic parameters in patients with UTUC. Here, FOXO3 is linked to renal pelvis/ureter urothelial carcinoma.